Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product
- PMID: 7691885
- PMCID: PMC288334
- DOI: 10.1172/JCI116761
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product
Abstract
The c-kit proto-oncogene encodes a receptor tyrosine kinase. Binding of c-kit ligand, stem cell factor (SCF) to c-kit receptor (c-kitR) is known to activate c-kitR tyrosine kinase, thereby leading to autophosphorylation of c-kitR on tyrosine and to association of c-kitR with substrates such as phosphatidylinositol 3-kinase (PI3K). In a human mast cell leukemia cell line HMC-1, c-kitR was found to be constitutively phosphorylated on tyrosine, activated, and associated with PI3K without the addition of SCF. The expression of SCF mRNA transcript in HMC-1 cells was not detectable by means of PCR after reverse transcription (RT-PCR) analysis, suggesting that the constitutive activation of c-kitR was ligand independent. Sequencing of whole coding region of c-kit cDNA revealed that c-kit genes of HMC-1 cells were composed of a normal, wild-type allele and a mutant allele with two point mutations resulting in intracellular amino acid substitutions of Gly-560 for Val and Val-816 for Asp. Amino acid sequences in the regions of the two mutations are completely conserved in all of mouse, rat, and human c-kit. In order to determine the causal role of these mutations in the constitutive activation, murine c-kit mutants encoding Gly-559 and/or Val-814, corresponding to human Gly-560 and/or Val-816, were constructed by site-directed mutagenesis and expressed in a human embryonic kidney cell line, 293T cells. In the transfected cells, both c-kitR (Gly-559, Val-814) and c-kitR (Val-814) were abundantly phosphorylated on tyrosine and activated in immune complex kinase reaction in the absence of SCF, whereas tyrosine phosphorylation and activation of c-kitR (Gly-559) or wild-type c-kitR was modest or little, respectively. These results suggest that conversion of Asp-816 to Val in human c-kitR may be an activating mutation and responsible for the constitutive activation of c-kitR in HMC-1 cells.
Similar articles
-
Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line.Leukemia. 1994 Apr;8 Suppl 1:S18-22. Leukemia. 1994. PMID: 7512180
-
Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3.Int Arch Allergy Immunol. 1995 Apr;106(4):377-85. doi: 10.1159/000236870. Int Arch Allergy Immunol. 1995. PMID: 7536501
-
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.Blood. 1995 Feb 1;85(3):790-8. Blood. 1995. PMID: 7530509
-
Structure-function analyses of the kit receptor for the steel factor.Stem Cells. 1993 Jul;11 Suppl 2:12-21. doi: 10.1002/stem.5530110804. Stem Cells. 1993. PMID: 7691317 Review.
-
The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis.Dev Suppl. 1993:125-37. Dev Suppl. 1993. PMID: 7519481 Review.
Cited by
-
Mast Cell and Basophil Cell Lines: A Compendium.Methods Mol Biol. 2020;2163:127-144. doi: 10.1007/978-1-0716-0696-4_10. Methods Mol Biol. 2020. PMID: 32766971 Review.
-
Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V.Haematologica. 2013 Sep;98(9):1450-7. doi: 10.3324/haematol.2012.079202. Epub 2013 Mar 28. Haematologica. 2013. PMID: 23539538 Free PMC article.
-
c-kit gene mutations in intracranial germinomas.Cancer Sci. 2004 Sep;95(9):716-20. doi: 10.1111/j.1349-7006.2004.tb03251.x. Cancer Sci. 2004. PMID: 15471556 Free PMC article.
-
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536.Haematologica. 2011 May;96(5):672-80. doi: 10.3324/haematol.2010.031328. Epub 2011 Jan 17. Haematologica. 2011. PMID: 21242189 Free PMC article.
-
Development of mast cells.Proc Jpn Acad Ser B Phys Biol Sci. 2007 Sep;83(6):164-74. doi: 10.2183/pjab.83.164. Proc Jpn Acad Ser B Phys Biol Sci. 2007. PMID: 24367142 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials